Vascular resection surgery for hilar cholangiocarcinoma
Part of Cancer clinical trials.
This study looks at whether removing a piece of a blood vessel along with the tumor during surgery helps people with hilar cholangiocarcinoma live longer and have fewer complications. It reviews past patient records to compare outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had surgery for hilar cholangiocarcinoma between January 2010 and December 2024.
- The tumor was confirmed to be hilar cholangiocarcinoma by a pathologist after surgery.
- You did not have cancer that spread to distant organs (distant metastasis).
- Your surgery was meant to remove the cancer, not just to relieve symptoms or explore.
- Your full medical records and follow-up information are available.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a surgery that removes only a small part of the liver to treat bile duct cancer where the bile ducts exit the liver. It may help people whose cancer has not spread beyond the bile duct area.
This trial tests whether combining proton beam therapy (a precise type of radiation) with a liver transplant can help people with a certain bile duct cancer (hilar cholangiocarcinoma). It may be a new option for those who cannot have surgery to remove the cancer.
This trial tests a combination of chemotherapy drugs (gemcitabine, cisplatin, nab-paclitaxel) with an immunotherapy (rilvegostomig) before and after surgery for intrahepatic cholangiocarcinoma that can be completely removed. It aims to see if this approach improves outcomes.
This study tests giving chemo and radiation before a liver transplant for an unresectable bile duct cancer near the liver (hCCA). If your cancer can’t be removed with surgery right now, this approach aims to shrink and control it so transplant may become an option.
This study tests whether robot-assisted surgery is safe and effective for people with perihilar cholangiocarcinoma (a type of bile duct cancer). It may be a good fit for patients whose cancer has not spread and who are healthy enough for major surgery.
This study looks at whether removing more lymph nodes while surgically removing an intrahepatic cholangiocarcinoma (bile duct cancer in the liver) improves outcomes. It may help by better checking and treating possible microscopic spread to lymph nodes.
Hear when a new Cholangiocarcinoma, Hilar trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.